KO

KOMIPHARM INTERNATIONAL CO., LTD.

Biopharmaceutical company developing products for animal and human health.

041960 | KO

Overview

Corporate Details

ISIN(s):
KR7041960006
LEI:
Country:
South Korea
Address:
경기도 시흥시 경제로 17, 시흥시

Description

Komipharm International Co., Ltd. is a biopharmaceutical company engaged in the development, manufacturing, and sale of products for both animal and human health. Its Animal Health Division provides a portfolio of veterinary vaccines, pharmaceuticals, and disinfectants. The company's Pharmaceutical Division is dedicated to the research and development of novel therapeutic agents, with key research areas including anticancer drugs and treatments for cancer-related pain and autoimmune diseases. Leveraging extensive experience, the company focuses on intensive R&D to expand its presence in the global bio-industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-26 00:00
주요사항보고서(자기주식취득결정)
Korean 32.7 KB
2025-03-26 00:00
[기재정정]주요사항보고서(자기주식취득결정)
Korean 35.5 KB
2025-03-18 00:00
감사보고서제출
Korean 25.4 KB
2025-03-18 00:00
사업보고서 (2024.12)
Korean 2.3 MB
2025-03-13 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 15.7 KB
2025-03-11 00:00
주주총회소집공고
Korean 193.7 KB
2025-03-11 00:00
의결권대리행사권유참고서류
Korean 168.5 KB
2025-02-25 00:00
주주총회소집결의
Korean 18.3 KB
2025-02-19 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.7 KB
2025-01-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.3 KB
2025-01-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2024-12-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2024-12-27 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.3 KB
2024-12-27 00:00
[기재정정]반기보고서 (2024.06)
Korean 1.7 MB
2024-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB

Automate Your Workflow. Get a real-time feed of all KOMIPHARM INTERNATIONAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOMIPHARM INTERNATIONAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOMIPHARM INTERNATIONAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.